Labiana Health, S.A. (BME:LAB)
6.55
0.00 (0.00%)
Last updated: Aug 6, 2026, 4:07 PM CET
Labiana Health Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 5.91 | 6.74 | 2.96 | 2.52 | 3.28 |
Cash & Short-Term Investments | 5.91 | 6.74 | 2.96 | 2.52 | 3.28 |
Cash Growth | -12.22% | 127.68% | 17.40% | -23.22% | 40.55% |
Accounts Receivable | 10.39 | 9.42 | 11.82 | 8.78 | - |
Other Receivables | 2.43 | 1.52 | 1.67 | 3.13 | - |
Total Trade Receivables | 12.82 | 10.94 | 13.48 | 11.91 | 10.95 |
Inventory | 12.41 | 10.68 | 12.37 | 13.83 | 14.92 |
Other Current Assets | 0 | 0.16 | 0.01 | 0.02 | 0.26 |
Total Current Assets | 31.53 | 28.7 | 28.98 | 28.76 | 29.41 |
Net Property, Plant & Equipment | 14.42 | 12.68 | 19.77 | 20.64 | 20.38 |
Other Intangible Assets | 6.19 | 6.03 | 7.68 | 9.04 | 12.74 |
Long-Term Investments | 1.42 | 2.11 | 0.89 | 1.42 | 4.4 |
Other Long-Term Assets | 3.97 | 2.48 | 1.8 | 0.92 | 1.44 |
Total Assets | 57.54 | 52 | 59.12 | 60.78 | 68.37 |
Accounts Payable | 11.37 | 8.77 | 8.76 | 11.33 | - |
Accrued Expenses | 2.11 | 2.62 | 2.87 | 2.32 | - |
Short-Term Debt | 5.21 | 6.82 | 9.64 | 10.53 | - |
Current Portion of Long-Term Debt | 0.99 | 0.78 | 0.84 | 9.05 | - |
Current Portion of Leases | 0.38 | 0.55 | 0.65 | 0.62 | - |
Unearned Revenue | 1 | 1.16 | 0.49 | 0.46 | - |
Other Current Liabilities | 1.62 | 1.46 | 1.44 | 0.76 | - |
Total Current Liabilities | 22.66 | 22.16 | 24.7 | 35.06 | 30.45 |
Long-Term Debt | 29.81 | 26.89 | 29.68 | 16.84 | - |
Long-Term Leases | 0.28 | 0.35 | 0.91 | 1.49 | - |
Other Long-Term Liabilities | 0.04 | 0.04 | 0.51 | 0.56 | 0.4 |
Total Long-Term Liabilities | 30.12 | 27.28 | 31.02 | 18.81 | 26.39 |
Total Liabilities | 52.79 | 49.43 | 55.72 | 53.87 | 68.37 |
Common Stock | 0.72 | 0.72 | 0.72 | 0.72 | - |
Treasury Stock | -0.92 | -0.71 | -0.2 | -0.29 | - |
Additional Paid-in Capital | 9.45 | 9.45 | 9.45 | 8.2 | - |
Retained Earnings | 7.64 | 5.17 | 0.18 | -4.05 | - |
Total Common Shareholders' Equity | 5.08 | 2.87 | 3.58 | 7.03 | - |
Minority Interest | -0.33 | -0.3 | -0.18 | -0.13 | - |
Shareholders' Equity | 4.76 | 2.57 | 3.4 | 6.91 | 11.52 |
Total Liabilities & Equity | 57.54 | 52 | 59.12 | 60.78 | 79.89 |
Total Debt | 36.67 | 35.39 | 41.72 | 38.52 | 0 |
Net Cash (Debt) | -30.75 | -28.65 | -38.76 | -36 | 3.28 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -4.27 | -3.98 | -5.38 | -5.00 | 0.53 |
Book Value | 5.08 | 2.87 | 3.58 | 7.03 | 0 |
Book Value Per Share | 0.71 | 0.40 | 0.50 | 0.98 | - |
Tangible Book Value | -1.11 | -3.16 | -4.1 | -2.01 | -12.74 |
Tangible Book Value Per Share | -0.15 | -0.44 | -0.57 | -0.28 | -2.06 |